Value of serum human epidermal growth factor receptor 2 (HER2)/neu testing for early prediction of response to HER2/neu-directed therapies is still an open one and deserves further study in large prospective trials.


TO THE EDITOR: The recent article by Lennon et al draws a very different conclusion about the value of the serum human epidermal growth factor receptor 2 (HER2)/neu test then did our previously published work by Ali et al. We wish to make the following observations. The number of patients who were HER2/neu tissue positive and treated with first-line… (More)
DOI: 10.1200/JCO.2009.23.4674



Citations per Year

fewer than 50 Citations

Semantic Scholar estimates that this publication has 50 citations based on the available data.

See our FAQ for additional information.

  • Presentations referencing similar topics